18 Nov 2024
// PR NEWSWIRE
30 Oct 2024
// PRESS RELEASE
29 Oct 2024
// PR NEWSWIRE
Latest Content by PharmaCompass
01 3ASENAPINE MALEATE
02 2ASPIRIN; BUTALBITAL; CAFFEINE
03 1ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
04 2BRIMONIDINE TARTRATE
05 2CHLORAMPHENICOL
06 1CHLORAMPHENICOL; PREDNISOLONE
07 1CROMOLYN SODIUM
08 1CYCLOSPORINE
09 1DEXAMETHASONE
10 2DICYCLOMINE HYDROCHLORIDE
11 3DILTIAZEM HYDROCHLORIDE
12 1DIPIVEFRIN HYDROCHLORIDE
13 4DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
14 1EPINASTINE HYDROCHLORIDE
15 1ESTRADIOL
16 4ETHINYL ESTRADIOL; NORETHINDRONE
17 1ETHOXZOLAMIDE
18 1FERRIC OXYHYDROXIDE
19 4FLUOCINOLONE ACETONIDE
20 1FLUOROMETHOLONE
21 1FLUOROMETHOLONE; SULFACETAMIDE SODIUM
22 1FLURBIPROFEN SODIUM
23 1GATIFLOXACIN
24 1GENTAMICIN SULFATE
25 2GENTAMICIN SULFATE; PREDNISOLONE ACETATE
26 5HYDROCORTISONE
27 2HYDROXYPROGESTERONE CAPROATE
28 1IDOXURIDINE
29 1KETOROLAC TROMETHAMINE
30 2LEVOBUNOLOL HYDROCHLORIDE
31 6LIOTRIX (T4;T3)
32 1MEDRYSONE
33 1MEMANTINE HYDROCHLORIDE
34 12MORPHINE SULFATE
35 1NAPHAZOLINE HYDROCHLORIDE
36 4NEBIVOLOL HYDROCHLORIDE
37 1NEDOCROMIL SODIUM
38 1NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PREDNISOLONE ACETATE
39 1OFLOXACIN
40 2OXYBUTYNIN
41 5OnabotulinumtoxinA
42 1PHENYLEPHRINE HYDROCHLORIDE; PYRILAMINE MALEATE
43 1PODOFILOX
44 1POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE
45 2PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
46 1PROPARACAINE HYDROCHLORIDE
47 1SELENIUM SULFIDE
48 3SULFACETAMIDE SODIUM
49 5TAZAROTENE
50 2TRETINOIN
51 1TRIAMCINOLONE ACETONIDE
52 3TRIMEPRAZINE TARTRATE
53 2TROSPIUM CHLORIDE
54 2URSODIOL
01 2AEROSOL;TOPICAL
02 21CAPSULE, EXTENDED RELEASE;ORAL
03 3CAPSULE;ORAL
04 7CREAM;TOPICAL
05 1CREAM;VAGINAL
06 1EMULSION; OPHTHALMIC
07 1FILM, EXTENDED RELEASE;TRANSDERMAL
08 1GEL, METERED;TRANSDERMAL
09 5GEL;TOPICAL
10 3INJECTABLE;INJECTION
11 1INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL
12 1LOTION/SHAMPOO;TOPICAL
13 6OINTMENT;OPHTHALMIC
14 2OINTMENT;TOPICAL
15 21SOLUTION/DROPS;OPHTHALMIC
16 1SOLUTION;ORAL
17 2SOLUTION;TOPICAL
18 3SUSPENSION/DROPS;OPHTHALMIC
19 2SUSPENSION;OPHTHALMIC
20 1SYRUP;ORAL
21 17TABLET;ORAL
22 2TABLET;ORAL-21
23 2TABLET;ORAL-28
24 3TABLET;SUBLINGUAL
25 5VIAL; SINGLE-USE
01 20.01%
02 10.01% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
03 10.0125MG;0.0031MG
04 30.025%
05 10.025MG;0.0063MG
06 10.03% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
07 20.035MG;0.5MG
08 20.035MG;1MG
09 10.0375%
10 30.05%
11 10.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
12 10.05MG;0.0125MG
13 10.075%
14 60.1%
15 10.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
16 10.1%;10%
17 10.12%;0.1%
18 10.15MG;0.0375MG
19 10.1MG;0.025MG
20 10.2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
21 20.2%;10%
22 10.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
23 10.25MG;0.0625MG
24 20.3%
25 60.5%
26 10.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
27 51%
28 11%;0.5%
29 210%
30 110,000 UNITS/ML;EQ 1MG BASE/ML
31 2100 UNITS/VIAL
32 1100MG
33 110MG
34 110MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
35 110MG;14MG
36 110MG;21MG
37 110MG;28MG
38 110MG;7MG
39 1120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
40 1125MG
41 1125MG/ML
42 1130MG
43 1150MG
44 1180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
45 12% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
46 22.5%
47 1200 UNITS/VIAL
48 1200MG
49 120MG
50 220MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
51 1240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
52 1250MG
53 1250MG/ML
54 12MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
55 13%
56 13.9MG/24HR
57 130%
58 130MG
59 2325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
60 1325MG;50MG;40MG;30MG
61 14% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
62 140MG
63 250 UNITS/VIAL
64 1500MG
65 150MG
66 160MG
67 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
68 170MG
69 180MG
70 18MG/0.1ML (8MG/0.1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
71 1EQ 0.3% BASE
72 1EQ 0.3% BASE;0.6%
73 1EQ 0.3% BASE;1%
74 1EQ 0.35% BASE;10,000 UNITS/ML;0.5%
75 1EQ 100MG IRON/2ML (EQ 50MG IRON/ML)
76 2EQ 10MG BASE
77 3EQ 2.5MG BASE
78 1EQ 2.5MG BASE/5ML
79 1EQ 20MG BASE
80 3EQ 5MG BASE
01 84DISCN
02 24RX
03 6Blank
RLD : Yes
TE Code : AB
Dosage Form : TABLET; SUBLINGUAL
Proprietary Name : SAPHRIS
Dosage Strength : EQ 5MG BASE
Approval Date : 2009-08-13
Application Number : 22117
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; SUBLINGUAL
Proprietary Name : SAPHRIS
Dosage Strength : EQ 10MG BASE
Approval Date : 2009-08-13
Application Number : 22117
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; SUBLINGUAL
Proprietary Name : SAPHRIS
Dosage Strength : EQ 2.5MG BASE
Approval Date : 2015-03-12
Application Number : 22117
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Federa...
Approval Date : 1986-04-16
Application Number : 17534
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : CAPSULE; ORAL
Proprietary Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Federa...
Approval Date : 1986-04-16
Application Number : 17534
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Dosage Form : CAPSULE; ORAL
Proprietary Name : FIORINAL W/CODEINE
Dosage Strength : 325MG;50MG;40MG;30MG
Approval Date : 1990-10-26
Application Number : 19429
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code :
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : ALPHAGAN
Dosage Strength : 0.5%
Approval Date : 1997-03-13
Application Number : 20490
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code :
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : ALPHAGAN
Dosage Strength : 0.2% **Federal Register ...
Approval Date : 1996-09-06
Application Number : 20613
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code :
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : CHLOROPTIC
Dosage Strength : 0.5%
Approval Date : 1982-01-01
Application Number : 50091
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Dosage Form : OINTMENT; OPHTHALMIC
Proprietary Name : CHLOROPTIC S.O.P.
Dosage Strength : 1%
Approval Date : 1982-01-01
Application Number : 61187
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
LOOKING FOR A SUPPLIER?